301103 何氏眼科
已收盘 07-19 15:00:00
资讯
新帖
简况
何氏眼科(301103.SZ)拟10股派6.050416元 于7月5日除权除息
智通财经 · 06-26
何氏眼科(301103.SZ)拟10股派6.050416元 于7月5日除权除息
6月24日何氏眼科创60日新低,申万菱信医药先锋股票A基金重仓该股
证券之星 · 06-24
6月24日何氏眼科创60日新低,申万菱信医药先锋股票A基金重仓该股
何氏眼科:公司是一家主要从事眼科医疗及眼健康服务的全生命周期眼健康服务的企业
证券之星 · 06-21
何氏眼科:公司是一家主要从事眼科医疗及眼健康服务的全生命周期眼健康服务的企业
何氏眼科(301103.SZ)完成回购1.72%股份 耗资6750万元
智通财经 · 06-20
何氏眼科(301103.SZ)完成回购1.72%股份 耗资6750万元
何氏眼科:公司将在充分保护投资者权益的前提下,结合公司经营需求认真考虑投资者合理化建议
证券之星 · 06-06
何氏眼科:公司将在充分保护投资者权益的前提下,结合公司经营需求认真考虑投资者合理化建议
何氏眼科:公司2023年度利润分配预案将于2024年6月19日提交2023年年度股东大会审议
证券之星 · 06-05
何氏眼科:公司2023年度利润分配预案将于2024年6月19日提交2023年年度股东大会审议
6月5日何氏眼科创60日新低,申万菱信医药先锋股票A基金重仓该股
证券之星 · 06-05
6月5日何氏眼科创60日新低,申万菱信医药先锋股票A基金重仓该股
何氏眼科(301103.SZ)累计回购1.71%股份 耗资6687.1万元
智通财经 · 06-03
何氏眼科(301103.SZ)累计回购1.71%股份 耗资6687.1万元
何氏眼科(301103)5月27日主力资金净卖出689.14万元
证券之星 · 05-28
何氏眼科(301103)5月27日主力资金净卖出689.14万元
何氏眼科:为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息
证券之星 · 05-27
何氏眼科:为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息
何氏眼科:为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息
证券之星 · 05-20
何氏眼科:为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息
何氏眼科:沈阳何氏眼产业集团有限公司系公司实际控制人控制的关联方企业
证券之星 · 05-16
何氏眼科:沈阳何氏眼产业集团有限公司系公司实际控制人控制的关联方企业
何氏眼科:详见已回复过的相关问题,请您翻阅互动易
证券之星 · 05-15
何氏眼科:详见已回复过的相关问题,请您翻阅互动易
何氏眼科(301103)5月14日主力资金净买入207.15万元
证券之星 · 05-15
何氏眼科(301103)5月14日主力资金净买入207.15万元
何氏眼科(301103)5月10日主力资金净卖出1761.60万元
证券之星 · 05-13
何氏眼科(301103)5月10日主力资金净卖出1761.60万元
何氏眼科:详见已回复过的相关问题,请您翻阅互动易
证券之星 · 05-09
何氏眼科:详见已回复过的相关问题,请您翻阅互动易
5月8日何氏眼科涨5.81%,申万菱信医药先锋股票A基金重仓该股
证券之星 · 05-08
5月8日何氏眼科涨5.81%,申万菱信医药先锋股票A基金重仓该股
山西证券:给予何氏眼科增持评级
证券之星 · 05-08
山西证券:给予何氏眼科增持评级
何氏眼科:为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息
证券之星 · 05-06
何氏眼科:为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息
何氏眼科(301103.SZ)累计回购1.32%股份 耗资5151.42万元
智通财经 · 05-06
何氏眼科(301103.SZ)累计回购1.32%股份 耗资5151.42万元
加载更多
公司概况
公司名称:
辽宁何氏眼科医院集团股份有限公司
所属行业:
卫生
上市日期:
2022-03-22
主营业务:
辽宁何氏眼科医院集团股份有限公司主营业务为面向眼病患者提供眼科专科诊疗服务和视光服务。公司的主要服务项目有白内障诊疗服务项目、屈光不正诊疗服务项目、玻璃体视网膜诊疗服务项目青光眼诊疗服务项目、干眼特色诊疗服务项目、中医特色诊疗服务项目。沈阳何氏眼科医院被评为“国家临床重点专科”、国际眼科理事会眼科专科医师培训基地、国家药物临床试验机构。
发行价格:
42.50
{"stockData":{"symbol":"301103","market":"SZ","secType":"STK","nameCN":"何氏眼科","latestPrice":21.05,"timestamp":1721372595000,"preClose":21.2,"halted":0,"volume":763599,"delay":0,"floatShares":83090100,"shares":158000000,"eps":0.226,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.15,"latestTime":"07-19 15:00:00","open":21,"high":21.35,"low":20.96,"amount":16146600,"amplitude":0.0184,"askPrice":21.05,"askSize":3,"bidPrice":21.04,"bidSize":17,"shortable":0,"etf":0,"ttmEps":0.226,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721611800000},"adr":0,"adjPreClose":21.2,"symbolType":"stock","openAndCloseTimeList":[[1721352600000,1721359800000],[1721365200000,1721372400000]],"highLimit":23.32,"lowLimit":19.08,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":158026471,"pbRate":1.62,"roa":"--","roe":"1.39%","epsLYR":0.4022,"committee":0.656716,"marketValue":3326000000,"floatMarketCap":1749000000,"peRate":93.141595,"changeRate":-0.0071,"turnoverRate":0.0092,"status":1},"requestUrl":"/m/hq/s/301103","defaultTab":"news","newsList":[{"id":"2446361451","title":"何氏眼科(301103.SZ)拟10股派6.050416元 于7月5日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2446361451","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446361451?lang=zh_cn&edition=full","pubTime":"2024-06-26 19:35","pubTimestamp":1719401755,"startTime":"0","endTime":"0","summary":"智通财经APP讯,何氏眼科(301103.SZ)公告,公司2023年年度权益分派向全体股东每10股派6.050416元人民币现金(含税)。除权除息日为:2024年7月5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1141038.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301103","BK0236"],"gpt_icon":0},{"id":"2445472760","title":"6月24日何氏眼科创60日新低,申万菱信医药先锋股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445472760","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445472760?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:36","pubTimestamp":1719218203,"startTime":"0","endTime":"0","summary":"证券之星消息,6月24日何氏眼科创60日新低,收盘报21.1元,当日跌4.87%,换手率1.15%,成交量9582.0手,成交额2050.5万元。重仓何氏眼科的公募基金请见下表:该股最近90天内共有1家机构给出评级,增持评级1家。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为申万菱信医药先锋股票A。申万菱信医药先锋股票A目前规模为2.13亿元,最新净值0.5313,较上一交易日下跌0.06%,近一年下跌36.26%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400021249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","301103","BK1161","BK0236","09939","BK1574","BK1515"],"gpt_icon":0},{"id":"2445369347","title":"何氏眼科:公司是一家主要从事眼科医疗及眼健康服务的全生命周期眼健康服务的企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2445369347","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445369347?lang=zh_cn&edition=full","pubTime":"2024-06-21 17:08","pubTimestamp":1718960939,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科06月21日在投资者关系平台上答复投资者关心的问题。业绩情况及投资业务情况请关注公司后续发布的定期报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062100036942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"gpt_icon":0},{"id":"2444264429","title":"何氏眼科(301103.SZ)完成回购1.72%股份 耗资6750万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444264429","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444264429?lang=zh_cn&edition=full","pubTime":"2024-06-20 16:16","pubTimestamp":1718871374,"startTime":"0","endTime":"0","summary":"智通财经APP讯,何氏眼科(301103.SZ)公告,截至2024年6月19日,公司累计回购股份272.27万股,占公司总股本的1.72%,最高成交价格为31.36元/股,最低成交价格为19.98元/股,成交总金额为6750.35万元(不含交易费用)。截至公告披露日,公司本次回购股份计划已实施完毕。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1137909.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301103","BK0236"],"gpt_icon":0},{"id":"2441791678","title":"何氏眼科:公司将在充分保护投资者权益的前提下,结合公司经营需求认真考虑投资者合理化建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2441791678","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441791678?lang=zh_cn&edition=full","pubTime":"2024-06-06 18:04","pubTimestamp":1717668277,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科06月06日在投资者关系平台上答复投资者关心的问题。公司将在充分保护投资者权益的前提下,结合公司经营需求认真考虑投资者合理化建议。针对眼科疾病诊疗服务请您联系何氏眼科当地医疗机构,感谢您的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060600036889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"gpt_icon":0},{"id":"2441474782","title":"何氏眼科:公司2023年度利润分配预案将于2024年6月19日提交2023年年度股东大会审议","url":"https://stock-news.laohu8.com/highlight/detail?id=2441474782","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441474782?lang=zh_cn&edition=full","pubTime":"2024-06-05 17:04","pubTimestamp":1717578265,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科06月05日在投资者关系平台上答复投资者关心的问题。公司2023年度利润分配预案将于2024年6月19日提交2023年年度股东大会审议。根据相关规则,公司将在年度股东大会审议通过后两个月内完成权益分派事宜。具体权益分派实施时间请关注公司后续披露的公告。公司如有收购其他公司股权等重大经营信息,将及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060500034555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"gpt_icon":0},{"id":"2441244612","title":"6月5日何氏眼科创60日新低,申万菱信医药先锋股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2441244612","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441244612?lang=zh_cn&edition=full","pubTime":"2024-06-05 16:31","pubTimestamp":1717576304,"startTime":"0","endTime":"0","summary":"证券之星消息,6月5日何氏眼科创60日新低,收盘报23.12元,当日跌2.65%,换手率1.29%,成交量1.07万手,成交额2521.18万元。重仓何氏眼科的公募基金请见下表:该股最近90天内共有1家机构给出评级,增持评级1家。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为申万菱信医药先锋股票A。申万菱信医药先锋股票A目前规模为2.13亿元,最新净值0.5553,较上一交易日下跌0.95%,近一年下跌38.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060500031998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","301103","09939","BK1161","159938","BK1515","BK0236"],"gpt_icon":0},{"id":"2440455166","title":"何氏眼科(301103.SZ)累计回购1.71%股份 耗资6687.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440455166","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440455166?lang=zh_cn&edition=full","pubTime":"2024-06-03 15:52","pubTimestamp":1717401163,"startTime":"0","endTime":"0","summary":"智通财经APP讯,何氏眼科(301103.SZ)公告,截至2024年5月31日,公司通过回购专用证券账户以集中竞价交易方式已累计回购公司股份269.67万股,占公司当前总股本的1.71%,最高成交价为31.36元/股,最低成交价为19.98元/股,成交总金额为6687.1万元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1129912.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0236","301103"],"gpt_icon":0},{"id":"2438367762","title":"何氏眼科(301103)5月27日主力资金净卖出689.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438367762","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438367762?lang=zh_cn&edition=full","pubTime":"2024-05-28 09:20","pubTimestamp":1716859239,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月27日收盘,何氏眼科报收于24.31元,下跌3.46%,换手率2.78%,成交量2.31万手,成交额5596.97万元。近5日资金流向一览见下表:何氏眼科融资融券信息显示,融资方面,当日融资买入539.27万元,融资偿还578.8万元,融资净偿还39.53万元。何氏眼科主营业务:面向眼病患者提供眼科专科诊疗服务和视光服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052800011972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"gpt_icon":0},{"id":"2438802858","title":"何氏眼科:为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2438802858","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438802858?lang=zh_cn&edition=full","pubTime":"2024-05-27 18:04","pubTimestamp":1716804267,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科05月27日在投资者关系平台上答复投资者关心的问题。投资者:请问截至2024年5月24日 公司股东人数 谢谢何氏眼科董秘:尊敬的投资者您好,为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700022041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"gpt_icon":0},{"id":"2436173286","title":"何氏眼科:为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2436173286","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436173286?lang=zh_cn&edition=full","pubTime":"2024-05-20 18:04","pubTimestamp":1716199472,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科05月20日在投资者关系平台上答复投资者关心的问题。投资者:请问截至2024年5月20日公司股东人数,谢谢何氏眼科董秘:尊敬的投资者您好,为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息。如确需查询其他时点的股东人数,根据相关法律法规规定,股东应当向公司提供证明其持有公司股份的种类以及持股数量的书面文件,公司经核实股东身份后按照股东的要求予以提供。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052000019628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"gpt_icon":0},{"id":"2435621278","title":"何氏眼科:沈阳何氏眼产业集团有限公司系公司实际控制人控制的关联方企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2435621278","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435621278?lang=zh_cn&edition=full","pubTime":"2024-05-16 17:03","pubTimestamp":1715850224,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科05月16日在投资者关系平台上答复投资者关心的问题。投资者:通报稿中:“何氏眼产业集团以高新技术为引领,打造了眼科机器人、生物药物、生物材料、干细胞治疗、基因治疗、合成生物学技术平台,自主研发的产品已销往全球87个国家和地区”。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051600025905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"gpt_icon":0},{"id":"2435768419","title":"何氏眼科:详见已回复过的相关问题,请您翻阅互动易","url":"https://stock-news.laohu8.com/highlight/detail?id=2435768419","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435768419?lang=zh_cn&edition=full","pubTime":"2024-05-15 17:05","pubTimestamp":1715763958,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科05月15日在投资者关系平台上答复投资者关心的问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500029873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"gpt_icon":0},{"id":"2435793875","title":"何氏眼科(301103)5月14日主力资金净买入207.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435793875","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435793875?lang=zh_cn&edition=full","pubTime":"2024-05-15 09:21","pubTimestamp":1715736099,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月14日收盘,何氏眼科报收于25.45元,下跌1.66%,换手率3.86%,成交量3.21万手,成交额8289.32万元。近5日资金流向一览见下表:何氏眼科融资融券信息显示,融资方面,当日融资买入801.27万元,融资偿还564.55万元,融资净买入236.72万元。何氏眼科主营业务:面向眼病患者提供眼科专科诊疗服务和视光服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500015459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"gpt_icon":0},{"id":"2435036075","title":"何氏眼科(301103)5月10日主力资金净卖出1761.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435036075","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435036075?lang=zh_cn&edition=full","pubTime":"2024-05-13 09:21","pubTimestamp":1715563318,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月10日收盘,何氏眼科报收于26.95元,下跌4.06%,换手率5.82%,成交量4.83万手,成交额1.34亿元。近5日资金流向一览见下表:何氏眼科融资融券信息显示,融资方面,当日融资买入625.73万元,融资偿还2314.04万元,融资净偿还1688.3万元。何氏眼科主营业务:面向眼病患者提供眼科专科诊疗服务和视光服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300001996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"gpt_icon":0},{"id":"2434640580","title":"何氏眼科:详见已回复过的相关问题,请您翻阅互动易","url":"https://stock-news.laohu8.com/highlight/detail?id=2434640580","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434640580?lang=zh_cn&edition=full","pubTime":"2024-05-09 18:04","pubTimestamp":1715249049,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科05月09日在投资者关系平台上答复投资者关心的问题。此外,辽宁省细胞生物学学会服务站落户公司全资子公司本溪何氏眼科医院,服务站的建立将促进双方在眼科干细胞精准医疗等领域的深入长期合作,并提供技术资源支持,共同为推进眼科医疗尖端技术进步做出贡献。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900032907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"gpt_icon":0},{"id":"2433711177","title":"5月8日何氏眼科涨5.81%,申万菱信医药先锋股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433711177","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433711177?lang=zh_cn&edition=full","pubTime":"2024-05-08 16:23","pubTimestamp":1715156626,"startTime":"0","endTime":"0","summary":"证券之星消息,5月8日何氏眼科涨5.81%,收盘报27.67元,换手率6.95%,成交量5.78万手,成交额1.57亿元。重仓何氏眼科的公募基金请见下表:该股最近90天内共有1家机构给出评级,增持评级1家。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为申万菱信医药先锋股票A。申万菱信医药先锋股票A目前规模为2.13亿元,最新净值0.615,较上一交易日上涨0.97%,近一年下跌38.19%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800027502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","BK1161","159938","BK1515","BK1574","301103","BK0236"],"gpt_icon":0},{"id":"2433762412","title":"山西证券:给予何氏眼科增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2433762412","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433762412?lang=zh_cn&edition=full","pubTime":"2024-05-08 10:55","pubTimestamp":1715136937,"startTime":"0","endTime":"0","summary":"山西证券股份有限公司叶中正,魏赟,冯瑞近期对何氏眼科进行研究并发布了研究报告《疫后需求释放驱动2023业绩增长,高基数拖累2024Q1同比增速》,本报告对何氏眼科给出增持评级,当前股价为26.42元。考虑到公司的眼健康医疗服务已逐步恢复至正常水平,维持“增持-B”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800019054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002500","301103"],"gpt_icon":0},{"id":"2433447005","title":"何氏眼科:为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2433447005","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433447005?lang=zh_cn&edition=full","pubTime":"2024-05-06 18:04","pubTimestamp":1714989897,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科05月06日在投资者关系平台上答复投资者关心的问题。投资者:请问截至2024年5月6日公司股东人数 谢谢何氏眼科董秘:尊敬的投资者您好,为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息。如确需查询其他时点的股东人数,根据相关法律法规规定,股东应当向公司提供证明其持有公司股份的种类以及持股数量的书面文件,公司经核实股东身份后按照股东的要求予以提供。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050600020567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"gpt_icon":0},{"id":"2433448631","title":"何氏眼科(301103.SZ)累计回购1.32%股份 耗资5151.42万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433448631","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433448631?lang=zh_cn&edition=full","pubTime":"2024-05-06 16:20","pubTimestamp":1714983631,"startTime":"0","endTime":"0","summary":"智通财经APP讯,何氏眼科(301103.SZ)公告,公司截至2024年4月30日以集中竞价交易方式已累计回购公司股份208.73万股,占公司当前总股本的1.32%,成交总金额为5151.42万元(不含交易费用)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0236","301103"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-03-22","address":"辽宁省沈阳市浑南区天赐街5-1号(607)","stockEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0357},{"period":"3month","weight":-0.1054},{"period":"6month","weight":-0.1953},{"period":"1year","weight":-0.4417},{"period":"ytd","weight":-0.2769}],"companyName":"辽宁何氏眼科医院集团股份有限公司","boardCode":"AI0083","perCapita":"7762股","boardName":"卫生","registeredCapital":"15802万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":" 辽宁何氏眼科医院集团股份有限公司主营业务为面向眼病患者提供眼科专科诊疗服务和视光服务。公司的主要服务项目有白内障诊疗服务项目、屈光不正诊疗服务项目、玻璃体视网膜诊疗服务项目青光眼诊疗服务项目、干眼特色诊疗服务项目、中医特色诊疗服务项目。沈阳何氏眼科医院被评为“国家临床重点专科”、国际眼科理事会眼科专科医师培训基地、国家药物临床试验机构。","serverTime":1721470765689,"listedPrice":42.5,"stockholders":"10704人(较上一季度增加3.05%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"何氏眼科(301103)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供何氏眼科(301103)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"何氏眼科,301103,何氏眼科股票,何氏眼科股票老虎,何氏眼科股票老虎国际,何氏眼科行情,何氏眼科股票行情,何氏眼科股价,何氏眼科股市,何氏眼科股票价格,何氏眼科股票交易,何氏眼科股票购买,何氏眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"何氏眼科(301103)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供何氏眼科(301103)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}